CCGView
RXA CCGView
With the RXA CCGView tool you can:
- Analyse up to 5 years of NHS prescribing and other sales data
- See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
- Select a range of reporting dimensions and filters
- GP Practice
- Product
- Brand vs. Generic
- Dispensing doctor
- Access extensive highly visual, easy to interpret analytics
- View extensive tables, charts and maps in the purpose built dashboard
- Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
Request your demonstration today
Andrew Norman, Director
Export to Excel is straightforward, which facilitates easy manipulation if required, for example, for territory planning.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Rx Analyser is used for territory planning, customer proposals, segmentation/targeting positioning, case studies demonstrating the benefits of working alongside us to drive formulary compliance, customer savings analysis and in the future reporting.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Fantastic customer service, any requests from us to fine tune the functionality or appearance of the product is done in most cases on the same day as the request.
National Sales Manager, UK Pharmaceutical Company
Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.
Andrew Norman and David Warwick, Directors
Benefits? The range of views of the data allows for easier business planning. The data being as up to date as possible enables swift response to market changes. And the ease of changing hierarchy allows for easy management reporting and oversight.
National Sales Manager, UK Pharmaceutical Company
Key benefits? Adaptability, flexibility for future changes and cloud-based.
